Published in Lancet on May 09, 1998
Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ (1999) 3.12
Incidence and case fatality rates of stroke subtypes in a multiethnic population: the South London Stroke Register. J Neurol Neurosurg Psychiatry (2002) 2.02
Hypertension and ethnic group. BMJ (2006) 1.57
Regulation of the epithelial sodium channel by membrane trafficking. Am J Physiol Renal Physiol (2008) 1.41
Associations between genetic variations in the FURIN gene and hypertension. BMC Med Genet (2010) 1.24
Role of epithelial sodium channels and their regulators in hypertension. J Biol Chem (2010) 1.20
Epithelial Na(+) channel regulation by cytoplasmic and extracellular factors. Exp Cell Res (2012) 1.08
Common variants in epithelial sodium channel genes contribute to salt sensitivity of blood pressure: The GenSalt study. Circ Cardiovasc Genet (2011) 1.06
Differences in hypertension between blacks and whites: an overview. Cardiovasc J Afr (2007) 1.03
Common variants of the beta and gamma subunits of the epithelial sodium channel and their relation to plasma renin and aldosterone levels in essential hypertension. BMC Med Genet (2005) 1.01
Regulation of the epithelial sodium channel (ENaC) by membrane trafficking. Biochim Biophys Acta (2010) 0.99
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
ENaCs and ASICs as therapeutic targets. Am J Physiol Cell Physiol (2012) 0.91
Epithelial sodium channel (ENaC) family: Phylogeny, structure-function, tissue distribution, and associated inherited diseases. Gene (2016) 0.89
A consideration of genetic mechanisms behind the development of hypertension in blacks. Curr Hypertens Rep (2013) 0.88
Role of the epithelial sodium channel in salt-sensitive hypertension. Acta Pharmacol Sin (2011) 0.88
Gain-of-function variant of the human epithelial sodium channel. Am J Physiol Renal Physiol (2012) 0.84
Multiple residues in the distal C terminus of the α-subunit have roles in modulating human epithelial sodium channel activity. Am J Physiol Renal Physiol (2012) 0.83
Prostasin: a possible candidate gene for human hypertension. Am J Hypertens (2008) 0.82
The R563Q mutation of the epithelial sodium channel beta-subunit is associated with hypertension. Cardiovasc J Afr (2010) 0.81
The genetics of essential hypertension. Br J Clin Pharmacol (2001) 0.81
Genetic variation in CYP4A11 and blood pressure response to mineralocorticoid receptor antagonism or ENaC inhibition: an exploratory pilot study in African Americans. J Am Soc Hypertens (2014) 0.80
Ion channels and the control of blood pressure. Br J Clin Pharmacol (2000) 0.80
Genetic mapping of a new heart rate QTL on chromosome 8 of spontaneously hypertensive rats. BMC Med Genet (2007) 0.79
Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.79
Novel treatment approaches in hypertensive type 2 diabetic patients. World J Diabetes (2014) 0.76
β-T594M epithelial sodium channel gene polymorphism and essential hypertension in individuals of Indo-Aryan ancestry in Northern India. Indian Heart J (2014) 0.75
The impact of molecular medicine upon early cardiovascular drug development. Br J Clin Pharmacol (2000) 0.75
Genetic polymorphisms in the beta-subunit of the epithelial sodium channel (βENaC) gene in the Japanese population. Clin Exp Nephrol (2002) 0.75
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest (1990) 10.35
Using patient and general practice characteristics to explain variations in cervical smear uptake rates. BMJ (1994) 9.81
British Hypertension Society guidelines for hypertension management 1999: summary. BMJ (1999) 8.80
Human hypertension caused by mutations in WNK kinases. Science (2001) 8.71
A comprehensive review on salt and health and current experience of worldwide salt reduction programmes. J Hum Hypertens (2008) 6.82
Survey of use of anticoagulation in patients with atrial fibrillation. BMJ (1993) 5.71
British Regional Heart Study: geographic variations in cardiovascular mortality, and the role of water quality. Br Med J (1980) 5.56
Prevalence of ischaemic heart disease in middle aged British men. Br Heart J (1984) 5.41
Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens (2002) 4.93
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Double-blind randomised trial of modest salt restriction in older people. Lancet (1997) 3.96
PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res (1992) 3.95
Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev (2004) 3.90
A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet (1993) 3.78
Using data from the 1991 census. BMJ (1995) 3.63
Diagnostic strategies in CADASIL. Neurology (2002) 3.52
Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet (1992) 3.33
Home visiting by general practitioners in England and Wales. BMJ (1996) 3.31
Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. J Biol Chem (1991) 3.22
Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci U S A (1988) 3.21
Increased consumption of fruit and vegetables is related to a reduced risk of coronary heart disease: meta-analysis of cohort studies. J Hum Hypertens (2007) 3.20
Health effects of passive smoking. 6. Parental smoking and childhood asthma: longitudinal and case-control studies. Thorax (1998) 3.19
Cardiovascular risk factors in British children from towns with widely differing adult cardiovascular mortality. BMJ (1996) 3.14
Renal artery stenosis masquerading as congestive heart failure. Lancet (1993) 3.10
Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet (1999) 3.08
Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet (1982) 3.07
Loss of employment and mortality. BMJ (1994) 3.06
Health of unemployed middle-aged men in Great Britain. Lancet (1982) 2.94
Early influences on blood pressure: a study of children aged 5-7 years. BMJ (1989) 2.90
Sociodemographic variables for general practices: use of census data. BMJ (1995) 2.90
Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol (2001) 2.85
Sarcoidosis, thyroiditis, and Addison's disease. Lancet (1970) 2.84
Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. Br Med J (1980) 2.75
Reliability of eliciting physical signs in examination of the chest. Lancet (1988) 2.71
Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. Clin Sci (Lond) (1998) 2.68
Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart (1997) 2.65
Natural genetic exchanges between vaccine and wild poliovirus strains in humans. J Virol (2000) 2.62
Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials. Ann Intern Med (1996) 2.62
Recall of diagnosis by men with ischaemic heart disease. Br Heart J (1984) 2.57
Explaining variation in hospital admission rates between general practices: cross sectional study. BMJ (1999) 2.56
A survey of intensive care unit visiting policies in the United Kingdom. Anaesthesia (2010) 2.52
Blood pressure in British children: associations with adult blood pressure and cardiovascular mortality. Lancet (1988) 2.51
Size at birth and blood pressure: cross sectional study in 8-11 year old children. BMJ (1997) 2.45
Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension (1994) 2.41
Genetically determined electrophoretic variations of human phosphogluconate dehydrogenase. Acta Genet Stat Med (1968) 2.39
Health effects of passive smoking. 1. Parental smoking and lower respiratory illness in infancy and early childhood. Thorax (1997) 2.36
The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am J Hum Genet (2001) 2.28
Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys. BMJ (2000) 2.28
Regression of area mortality rates on explanatory variables: what weighting is appropriate? J R Stat Soc Ser C Appl Stat (1981) 2.26
Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care. Heart (2005) 2.24
Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus infection. Lancet (1989) 2.23
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest (1997) 2.23
Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest (1996) 2.20
Evolution of statin prescribing 1994-2001: a case of agism but not of sexism? Heart (2003) 2.20
Giving up smoking and the risk of heart attacks. A report from The British Regional Heart Study. Lancet (1986) 2.19
Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet (1989) 2.19
Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19
Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation (1999) 2.17
Salt--more adverse effects. Lancet (1996) 2.17
Is "idiopathic" edema idiopathic? Lancet (1979) 2.11
What factors are associated with physical activity in older people, assessed objectively by accelerometry? Br J Sports Med (2008) 2.07
Is body mass index before middle age related to coronary heart disease risk in later life? Evidence from observational studies. Int J Obes (Lond) (2009) 2.05
Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int (1980) 2.01
Is the clinical trial evidence about new drugs statistically adequate? Br J Clin Pharmacol (1985) 2.01
Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart (2002) 1.98
Chronic exposure to outdoor air pollution and lung function in adults. Thorax (2009) 1.98
Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci U S A (1993) 1.96
A critical review of the effect of factory closures on health. Br J Ind Med (1991) 1.95
Trends in secondary prevention of ischaemic heart disease in the UK 1994 2005: use of individual and combination treatment. Heart (2007) 1.87
The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J Biol Chem (1991) 1.86
Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 1.84
Diuretic-induced oedema. Lancet (1975) 1.84
Complete amino acid sequence and maturation of the mouse submaxillary gland renin precursor. Nature (1982) 1.83
Moderate potassium supplementation in essential hypertension. Lancet (1982) 1.83
Age of menarche in contemporary British teenagers: survey of girls born between 1982 and 1986. BMJ (2001) 1.81
Echocardiography overestimates left ventricular mass: a comparative study with magnetic resonance imaging in patients with hypertension. J Hypertens (1996) 1.81
Measurement of plasma renin activity by radioimmunoassay after prolonged cold storage. Clin Chim Acta (1978) 1.77
The Dinamap 1846SX automated blood pressure recorder: comparison with the Hawksley random zero sphygmomanometer under field conditions. J Epidemiol Community Health (1992) 1.77
Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke (1995) 1.77
ABO blood group and ischaemic heart disease in British men. BMJ (1990) 1.76
The measurement of angiotensin-converting enzyme in subjects receiving captopril. N Engl J Med (1980) 1.72
The effects of adiposity and weight change on forced expiratory volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord (1999) 1.72
Familial Guillain-Barré syndrome. Lancet (1965) 1.71
Non-employment and changes in smoking, drinking, and body weight. BMJ (1992) 1.68
Do maternal and intrauterine factors influence blood pressure in childhood? Arch Dis Child (1992) 1.66
Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem (1991) 1.65
Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front Neuroendocrinol (1997) 1.65